<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
    <id>https://news.daum.net/digital</id>
    <title>다음뉴스 ─ IT ─ 메인뉴스</title>
    <updated>2023-11-12T07:18:39.118Z</updated>
    <generator>https://github.com/jpmonette/feed</generator>
    <icon>https://news.daum.net/favicon.ico</icon>
    <entry>
        <title type="html"><![CDATA[[ZD브리핑] 지스타 2023 16일 개막...카카오T 긴급간담회 주목]]></title>
        <id>https://v.daum.net/v/20231112140248655</id>
        <link href="https://v.daum.net/v/20231112140248655"/>
        <updated>2023-11-12T07:17:54.109Z</updated>
        <content type="html"><![CDATA[지디넷코리아]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[5G 가입자 증가율 0%…"LTE에서 갈아탈 매력 없어"]]></title>
        <id>https://v.daum.net/v/20231112155407915</id>
        <link href="https://v.daum.net/v/20231112155407915"/>
        <updated>2023-11-12T07:17:54.117Z</updated>
        <content type="html"><![CDATA[아시아경제]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[[단독]양양군, 설악산케이블카 적자를 흑자로 포장···경제적 편익 1200억 넘게 부풀려]]></title>
        <id>https://v.daum.net/v/20231112153915595</id>
        <link href="https://v.daum.net/v/20231112153915595"/>
        <updated>2023-11-12T07:17:54.122Z</updated>
        <content type="html"><![CDATA[경향신문]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA["수수료 안 높아"VS"낮춰야"…갈길 먼 카카오 택시 갈등]]></title>
        <id>https://v.daum.net/v/20231112150808002</id>
        <link href="https://v.daum.net/v/20231112150808002"/>
        <updated>2023-11-12T06:22:49.724Z</updated>
        <content type="html"><![CDATA[이데일리]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[한국기업 참여 미국 첫 '소형모듈원자로' 구축 무산]]></title>
        <id>https://v.daum.net/v/20231112150012777</id>
        <link href="https://v.daum.net/v/20231112150012777"/>
        <updated>2023-11-12T06:22:49.729Z</updated>
        <content type="html"><![CDATA[동아사이언스]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[백신·인공육 만드는 '합성생물학'…'바이오파운드리'가 성장해법]]></title>
        <id>https://v.daum.net/v/20231112145521701</id>
        <link href="https://v.daum.net/v/20231112145521701"/>
        <updated>2023-11-12T06:22:49.729Z</updated>
        <content type="html"><![CDATA[뉴스1]]></content>
    </entry>
</feed>